FDA Approved: NUPLAZID — Original Application (Acadia Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Nuplazid (pimavanserin tartrate) from Acadia Pharmaceuticals in its original NDA, for the treatment of hallucinations and delusions in Parkinso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinson Disease Psychosis

Drugs mentioned

• Nuplazid (Pimavanserin)

Snippet

ORIG AP for NUPLAZID (PIMAVANSERIN TARTRATE)